M6PR/IGF2R double-knockout supplies therapeutic sources for mucolipidosis II and Niemann-Pick C2

Toshiharu Fujita, Seigo Terawaki, Takahito Moriwaki, Takanobu Otomo · 2026

Read M6PR/IGF2R double-knockout supplies therapeutic sources for mucolipidosis II and Niemann-Pick C2 by Toshiharu Fujita, Seigo Terawaki, Takahito Moriwaki, Takanobu Otomo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13631582.txt.

Description

Toshiharu Fujita, Seigo Terawaki, Takahito Moriwaki, and Takanobu Otomo create receptor free cells whose culture fluid may treat two lysosomal storage diseases. Many lysosomal enzymes need a mannose phosphate tag and its receptors to reach lysosomes. Knocking out both receptor genes makes cells secrete tagged proteins into the medium instead of importing them.

That secreted fluid restores enzyme activity in cells from mucolipidosis II, a disease where dozens of enzymes go missing inside cells. Inclusion bodies shrink and autophagy improves. Patient fibroblasts gain enzyme activity, normal shape, and better survival after freezing. The fluid also supplies a partner protein missing in Niemann-Pick C2 disease. One engineered source may thus serve several rare disorders.

Catalog record

CREATORToshiharu Fujita, Seigo Terawaki, Takahito Moriwaki, Takanobu Otomo
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE55 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13631582

Browse the full library · About the Tower of Babel